IM Cannabis Names Ronen Zalayet CEO, Succeeding Oren Shuster

PUBT · 1d ago
IM Cannabis Names Ronen Zalayet CEO, Succeeding Oren Shuster
  • IM Cannabis appointed Nexera Technologies CFO Ronen Zalayet CEO effective November 19, 2026, succeeding Oren Shuster.
  • Oren Shuster also resigned from the board and as CEO of Israeli subsidiary Focus Medical Herbs, effective November 19, 2026.
  • Shakked Shuster, formerly head of product and marketing, became Focus Medical Herbs CEO on November 19, 2026.
  • Ohad Melnik became an independent director effective November 19, 2026, filling the vacancy left by Einat Zakariya's September 2026 resignation.
  • Melnik previously served as a Formula Systems director from January 2019 to May 2024.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IM Cannabis Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN03137) on November 20, 2026, and is solely responsible for the information contained therein.